On January 10, 2020 CEL-SCI Corporation (NYSE American: CVM) reported its Chief Executive Officer Geert Kersten will attend two upcoming healthcare investor conferences in San Francisco and New York (Press release, Cel-Sci, JAN 10, 2020, View Source [SID1234552990]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Event: 38th Annual JP Morgan Healthcare Conference
Date: January 13-16, 2020
Location: San Francisco, CA
Event: BIO CEO & Investor Conference
Date: February 10-11, 2020
Location: New York, NY
"We look forward to partnering and networking meetings at both the JP Morgan and the BIO CEO conferences. As we approach the end of our global pivotal Phase 3 advanced primary head and neck cancer study, this is an opportune time to meet with key industry stakeholders regarding our cancer immunotherapy Multikine*, which could potentially become the first FDA approved drug for this indication in about 60 years," Mr. Kersten stated.